136 related articles for article (PubMed ID: 33626451)
1. Targeting GRP receptor: Design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin.
Palmioli A; Nicolini G; Tripodi F; Orsato A; Ceresa C; Donzelli E; Arici M; Coccetti P; Rocchetti M; La Ferla B; Airoldi C
Bioorg Chem; 2021 Apr; 109():104739. PubMed ID: 33626451
[TBL] [Abstract][Full Text] [Related]
2. On-cell saturation transfer difference NMR study of Bombesin binding to GRP receptor.
Palmioli A; Ceresa C; Tripodi F; La Ferla B; Nicolini G; Airoldi C
Bioorg Chem; 2020 Jun; 99():103861. PubMed ID: 32339813
[TBL] [Abstract][Full Text] [Related]
3. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
4. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
[TBL] [Abstract][Full Text] [Related]
5. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
Koppán M; Halmos G; Arencibia JM; Lamharzi N; Schally AV
Cancer; 1998 Oct; 83(7):1335-43. PubMed ID: 9762934
[TBL] [Abstract][Full Text] [Related]
6. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
7. Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor.
Begum AA; Moyle PM; Toth I
Bioorg Med Chem; 2016 Nov; 24(22):5834-5841. PubMed ID: 27670095
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity.
Iwabuchi M; Ui-Tei K; Yamada K; Matsuda Y; Sakai Y; Tanaka K; Ohki-Hamazaki H
Br J Pharmacol; 2003 Jun; 139(3):555-66. PubMed ID: 12788815
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
10. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
11. Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer.
Hohla F; Schally AV
Cell Cycle; 2010 May; 9(9):1738-41. PubMed ID: 20473035
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
13. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor.
Williams BY; Dion SB; Schonbrunn A
Mol Pharmacol; 1998 Nov; 54(5):889-98. PubMed ID: 9804624
[TBL] [Abstract][Full Text] [Related]
14. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
17. Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
Accardo A; Salsano G; Morisco A; Aurilio M; Parisi A; Maione F; Cicala C; Tesauro D; Aloj L; De Rosa G; Morelli G
Int J Nanomedicine; 2012; 7():2007-17. PubMed ID: 22619538
[TBL] [Abstract][Full Text] [Related]
18. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
19. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
20. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]